Breast Cancer Screening With Imaging: Recommendations From the Society of Breast Imaging and the ACR on the Use of Mammography, Breast MRI, Breast Ultrasound, and Other Technologies for the Detection of Clinically Occult Breast Cancer

Lee, Carol H.; Dershaw, D. David; Kopans, Daniel B.; Evans, Philip; Monsees, Barbara; Monticciolo, Debra L.; Brenner, R. James; Bassett, Lawrence W.; Berg, Wendie A.; Feig, Stephen A.; Hendrick, Edward; Mendelson, Ellen B.; D’Orsi, Carl J.; Sickles, Edward A.; Burhenne, Linda Warren

doi:10.1016/j.jacr.2009.09.022

Cited by 699 publications

(489 citation statements)

References 75 publications

Supporting

Mentioning

468

Contrasting

Unclassified

Order By: Relevance

“…In November 2009, the US Preventive Services Task Force (USPSTF) recommended that women aged 50 and older undergo routine screening mammography every 2 years [8]. Earlier USPSTF recommendations and those of the American Cancer Society and the American College of Radiology recommended beginning annual screening for women 40 years of age and older [9,10].…”

Section: Introductionmentioning

confidence: 99%

Characteristics of US Counties with No Mammography Capacity

et al. 2012

View full text Add to dashboard Cite

Access to screening mammography may be limited by the availability of facilities and machines, and nationwide mammography capacity has been declining. We assessed nationwide capacity at state and county levels from 2003 to 2009, the most recent year for which complete data were available. Using mammography facility certification and inspection data from the Food and Drug Administration, we geocoded all mammography facilities in the United States and determined the total number of fully accredited mammography machines in each US County. We categorized mammography capacity as counties with zero capacity (i.e., 0 machines) or counties with capacity (i.e.,≥1 machines), and then compared those two categories by sociodemographic, health care, and geographic characteristics. We found that mammography capacity was not distributed equally HHS Public Access Author Manuscript Author ManuscriptAuthor ManuscriptAuthor Manuscript across counties within states and that more than 27 % of counties had zero capacity. Although the number of mammography facilities and machines decreased slightly from 2003 to 2009, the percentage of counties with zero capacity changed little. In adjusted analyses, having zero mammography capacity was most strongly associated with low population density (OR = 11.0; 95 % CI 7.7-15.9), low primary care physician density (OR = 8.9; 95 % CI 6.8-11.7), and a low percentage of insured residents (OR = 3.3; 95 % CI 2.5-4.3) when compared with counties having at least one mammography machine. Mammography capacity has been and remains a concern for a portion of the US population-a population that is mostly but not entirely rural.

show abstract

Section: Introductionmentioning

confidence: 99%

Characteristics of US Counties with No Mammography Capacity

et al. 2012

View full text Add to dashboard Cite

show abstract

“…The American College of Radiologists (ACR) and the European Society of Breast Imaging (EUSOBI) combine a woman's hereditary risk with age at diagnosis in the family in their screening advice although in different ways. 14,15 The ACR advises screening for all three risk-groups from 30 or 10 years of age earlier than the age at diagnosis of the youngest affected relative, whichever is later. 14 The EUSOBI advises screening from 30 years of age, and 5 years younger than the youngest relative.…”

Section: Early Detection and Diagnosismentioning

confidence: 99%

“…14,15 The ACR advises screening for all three risk-groups from 30 or 10 years of age earlier than the age at diagnosis of the youngest affected relative, whichever is later. 14 The EUSOBI advises screening from 30 years of age, and 5 years younger than the youngest relative. 15 This guideline appeared safe in all three risk groups in our data.…”

Section: Early Detection and Diagnosismentioning

confidence: 99%

“…Most guidelines advise either starting at a fixed age depending only on risk group (e.g., 25 or 30 years in BRCA1 or BRCA2 carriers), [11][12][13] or take into account the age of the youngest affected relative. 14,15 Aside from financial burden, risk reduction strategies have documented side effects, such as false-positive screening results and anxiety. 16 Also, more than 50% of BRCA1 and BRCA2 mutation carriers who opt for preventive mastectomy at 25-30 years of age would not have developed breast cancer before the age of 50 years.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Optimal age to start preventive measures in women with BRCA1/2 mutations or high familial breast cancer risk

Tilanus-Linthorst

Lingsma

Evans

et al. 2013

Intl Journal of Cancer

View full text Add to dashboard Cite

Women from high-risk families consider preventive measures for breast cancer including screening. Guidelines on screening differ considerably regarding starting age. We investigated whether age at diagnosis in affected relatives is predictive for age at diagnosis. We analyzed the age of breast cancer detection of 1,304 first-and second-degree relatives of 314 BRCA1, 164 BRCA2 and 244 highrisk participants of the Dutch MRI-SCreening study. The within-and between-family variance in the relative's age at diagnosis was analyzed with a random effect linear regression model. We compared the starting age of screening based on risk-group (25 years for BRCA1, 30 years for BRCA2 and 35 years for familial risk), on family history, and on the model, which combines both. The findings were validated in 63 families from the UK-MARIBS study. Mean age at diagnosis in the relatives varied between families; 95% range of mean family ages was 35-55 in BRCA1-, 41-57 in BRCA2-and 44-60 in high-risk families. In all, 14% of the variance in age at diagnosis, in BRCA1 even 23%, was explained by family history, 7% by risk group. Determining start of screening based on the model and on risk-group gave similar results in terms of cancers missed and years of screening. The approach based on familial history only, missed more cancers and required more screening years in both the Dutch and the United Kingdom data sets. Age at breast cancer diagnosis is partly dependent on family history which may assist planning starting age for preventive measures.The average risk of detecting breast cancer between 50 and 70 years of age is 5-6% for women in the United States and Europe. A woman's risk of developing breast cancer increases when a first-degree relative has had breast cancer progressively with decreasing age at onset in the relative 1 and with an increasing number of family members with breast and/or ovarian cancer. 1-3 Very high risk and young age at onset are seen in women with a BRCA1 or BRCA2 mutation, who have a cumulative lifetime risk of 45-80%. [2][3][4][5] Screening with MRI or other preventive measures such as preventive mastectomy are considered appropriate in these groups from 25 to 30 years onward. However, in about 80% of families that meet the criteria for BRCA testing no causative gene mutation can be detected currently. 6 These women are considered as having an increased familial risk.Screening and preventive surgery should ideally be tailored to the expected age of breast cancer onset. The estimated risk at a given age differs considerably between studies, both for BRCA1/2 mutation carriers and for women

show abstract

“…In amerikanischen Leitlinien wird die Integration des Ultraschalls der Brust sehr unterschiedlich gesehen und durch einen Versorgungsengpass für nicht durchführbar erklärt: "Clearly, it would not be feasible, given the current shortage of radiologists who perform breast imaging, for all women whose only risk factor is breast density to undergo radiologist-performed supplemental ultrasound screening." [20].…”

unclassified

AG Mamma – Konsensustreffen der Kursleiter in der Mammadiagnostik am 04.05.2013 in Frankfurt am Main – Standards in Technik und Befundung

2014

Fortschr Röntgenstr

View full text Add to dashboard Cite

Breast Cancer Screening With Imaging: Recommendations From the Society of Breast Imaging and the ACR on the Use of Mammography, Breast MRI, Breast Ultrasound, and Other Technologies for the Detection of Clinically Occult Breast Cancer

Cited by 699 publications

References 75 publications

Characteristics of US Counties with No Mammography Capacity

Characteristics of US Counties with No Mammography Capacity

Optimal age to start preventive measures in women with BRCA1/2 mutations or high familial breast cancer risk

AG Mamma – Konsensustreffen der Kursleiter in der Mammadiagnostik am 04.05.2013 in Frankfurt am Main – Standards in Technik und Befundung

Contact Info

Product

Resources

About